126 related articles for article (PubMed ID: 12713812)
1. Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome.
Casorelli I; Offman J; Mele L; Pagano L; Sica S; D'Errico M; Giannini G; Leone G; Bignami M; Karran P
DNA Repair (Amst); 2003 May; 2(5):547-59. PubMed ID: 12713812
[TBL] [Abstract][Full Text] [Related]
2. High level of microsatellite instability but not hypermethylation of mismatch repair genes in therapy-related and secondary acute myeloid leukaemia and myelodysplastic syndrome.
Sheikhha MH; Tobal K; Liu Yin JA
Br J Haematol; 2002 May; 117(2):359-65. PubMed ID: 11972518
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability.
Murata H; Khattar NH; Kang Y; Gu L; Li GM
Oncogene; 2002 Aug; 21(37):5696-703. PubMed ID: 12173039
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia.
Seedhouse CH; Das-Gupta EP; Russell NH
Leukemia; 2003 Jan; 17(1):83-8. PubMed ID: 12529664
[TBL] [Abstract][Full Text] [Related]
5. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
6. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
[TBL] [Abstract][Full Text] [Related]
8. Defective mismatch repair and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers.
Takahashi Y; Kondo K; Hirose T; Nakagawa H; Tsuyuguchi M; Hashimoto M; Sano T; Ochiai A; Monden Y
Mol Carcinog; 2005 Mar; 42(3):150-8. PubMed ID: 15605365
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability.
Bevilacqua RA; Simpson AJ
Int J Cancer; 2000 Jul; 87(2):200-3. PubMed ID: 10861474
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
[TBL] [Abstract][Full Text] [Related]
13. Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability.
Fang DC; Wang RQ; Yang SM; Yang JM; Liu HF; Peng GY; Xiao TL; Luo YH
World J Gastroenterol; 2003 Apr; 9(4):655-9. PubMed ID: 12679904
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability in hereditary and sporadic breast cancers.
Adem C; Soderberg CL; Cunningham JM; Reynolds C; Sebo TJ; Thibodeau SN; Hartmann LC; Jenkins RB
Int J Cancer; 2003 Nov; 107(4):580-2. PubMed ID: 14520695
[TBL] [Abstract][Full Text] [Related]
15. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
16. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.
Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G
Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843
[TBL] [Abstract][Full Text] [Related]
17. [Hypermethylation of hMLH1 and microsatellite instability in ovarian mucinous tumors].
Chen HZ; Ye DF; Xie X; Hu M; Lu WG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):457-61. PubMed ID: 12974095
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia.
Fleisher AS; Esteller M; Tamura G; Rashid A; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Nishizuka S; James SP; Wilson KT; Herman JG; Meltzer SJ
Oncogene; 2001 Jan; 20(3):329-35. PubMed ID: 11313962
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
Marcus VA; Madlensky L; Gryfe R; Kim H; So K; Millar A; Temple LK; Hsieh E; Hiruki T; Narod S; Bapat BV; Gallinger S; Redston M
Am J Surg Pathol; 1999 Oct; 23(10):1248-55. PubMed ID: 10524526
[TBL] [Abstract][Full Text] [Related]
20. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
